Advancements in synthetic biology have driven significant progress in chemical production using engineered microbes, yet challenges persist in characterizing strains and identifying optimal process conditions. This study introduces differential mobility spectrometry (DMS), a technique that ionizes and separates gaseous molecules in high and low electric fields, as a novel approach to monitor bioprocesses. We applied DMS to a bioprocess unit producing alpha-olefin 1-undecene, an industrially relevant platform chemical, through genetically engineered Acinetobacter baylyi ADP1 cells. DMS effectively captured the dynamic nature of 1-undecene production, demonstrating its potential as a nontargeted method for real-time bioprocess studies and optimizations.
No takes yet. Share an insight, caveat, or question.
Salmela et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: